# Fresenius Kabi to acquire infusion pump maker Ivenix for $240M upfront

Germany's Fresenius Kabi signed a definitive agreement to acquire US-based medical technology firm Ivenix. The deal includes an upfront payment of $240 million plus milestone payments tied to commercial and operating targets, with closing expected mid-2022.

- Type: Acquisition
- Announced: 2022-04-01
- Where: United States
- Value: $240.0M
- Status: announced
- Products: infusion system, large volume infusion pump, infusion management software
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fresenius Kabi](https://endata.com/companies/9091.md) (acquirer)
- [Ivenix](https://endata.com/companies/9092.md) (target)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/fresenius-kabi-ivenix/), 2022-04-01: "German healthcare company Fresenius Kabi has signed a definitive agreement to acquire US-based medical technology firm Ivenix."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.